Logout By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Omicron COVID-19 variant is mutating and has been forming new sub-variants, at this time experts are saying that only vaccines can keep individuals safe from catching the virus infection. However, in a recent study which was published in The Lancet Infectious Diseases journal, researchers have revealed that two doses of Chinese COVID-19 vaccine Sinopharm produced nothing or only minimally detectable neutralising activity against some Omicron sub-variants.
However, the study authors said that a third dose of the vaccine was found partly restore the neutralising activities against Omicron variants. "In the study, we found that the neutralising activity against Omicron sub-variants such as BA.1, BA.2, BA.2.11, BA.2.12.1, BA.2.13, and BA.4/BA.5 "was not or only minimally detectable".
The researchers further added that the neutralising activity against these sub-variants was observed in 24-48 per cent of people who received a BBIBP-CorV booster post a two-dose shot. The same was found to be improved by 30-53 per cent among 30 participants who received the third dose of another Covid vaccine ZF2001.
The study results also showed that the BA.2.12.1 subvariant were found to have a significantly more resistance than the BA.2 subvariant to a BBIBP-CorV booster, and the BA.2.11, BA.2.12.1, and BA.2.13 sub-variants showed significantly more resistance than the BA.2 subvariant to a ZF2001 booster.
As discussed above, Omicron is mutating and new sub-variants are here. To understand more about it, let's take a look at how many Omicron sub-variants are there right now: BA.1, BA.2, BA.3, BA.2.11, BA.2.12.1, BA.2.13, BA.4, and BA.5.
(With inputs from IANS)
Follow us on